Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jun 1;31(6):854-860.
doi: 10.5551/jat.RV22017. Epub 2024 Apr 13.

In the Beginning, Lipoproteins Cross the Endothelial Barrier

Affiliations
Review

In the Beginning, Lipoproteins Cross the Endothelial Barrier

Ira J Goldberg et al. J Atheroscler Thromb. .

Abstract

Atherosclerosis begins with the infiltration of cholesterol-containing lipoproteins into the arterial wall. White blood cell (WBC)-associated inflammation follows. Despite decades of research using genetic and pharmacologic methods to alter WBC function, in humans, the most effective method to prevent the initiation and progression of disease remains low-density lipoprotein (LDL) reduction. However, additional approaches to reducing cardiovascular disease would be useful as residual risk of events continues even with currently effective LDL-reducing treatments. Some of this residual risk may be due to vascular toxicity of triglyceride-rich lipoproteins (TRLs). Another option is that LDL transcytosis continues, albeit at reduced rates due to lower circulating levels of this lipoprotein. This review will address these two topics. The evidence that TRLs promote atherosclerosis and the processes that allow LDL and TRLs to be taken up by endothelial cells leading to their accumulation with the subendothelial space.

PubMed Disclaimer

Conflict of interest statement

None.

Similar articles

References

    1. Page IH: Atherosclerosis. An Introduction. Lewis A. Connor Memorial Lecture. Circulation, 1954; 10: 1-27 - PubMed
    1. Ross R: Atherosclerosis--an inflammatory disease. N Engl J Med, 1999; 340: 115-126 - PubMed
    1. Moore KJ, Tabas I: Macrophages in the pathogenesis of atherosclerosis. Cell, 2011; 145: 341-355 - PMC - PubMed
    1. Bjorkegren JLM, Lusis AJ: Atherosclerosis: Recent developments. Cell, 2022; 185: 1630-1645 - PMC - PubMed
    1. Goldberg IJ, Blaner WS, Vanni TM, Moukides M, Ramakrishnan R: Role of lipoprotein lipase in the regulation of high density lipoprotein apolipoprotein metabolism. Studies in normal and lipoprotein lipase-inhibited monkeys. J Clin Invest, 1990; 86: 463-473 - PMC - PubMed